Skip to main content
. 2020 Aug 25;12(8):e10020. doi: 10.7759/cureus.10020

Table 1. Transaminase level at baseline and during intravenous immunoglobulin infusion.

GBS, Guillain-Barré syndrome; AMAN, acute motor axonal neuropathy; AIDP, acute inflammatory demyelinating polyneuropathy; AMSAN, acute motor sensory axonal neuropathy; U/L, units per liter; AST, aspartate transaminase; ALT, alanine transaminase.

Serial Number Age (Years) Sex Name of Autoimmune Disorder AST Level (U/L) Baseline AST Level (U/L) During Treatment ALT Level (U/L) Baseline ALT Level (U/L) During Treatment
1 16 Male GBS (AMSAN) 20 40.25 88 92.5
2 17 Male GBS (AMSAN) 47 31 35 29
3 25 Female GBS (AMAN) 24 138.25 31 155.16
4 26 Female GBS (AIDP) 36 130 24 244
5 31 Male GBS (AIDP) 30 168.66 45 200.16
6 35 Male GBS (AIDP) 37 144.66 40 278
7 45 Female GBS (AMSAN) 30 222 32 169
8 50 Male GBS (AIDP) 29 57 38 138
9 56 Female GBS (AIDP) 21 54.5 23 35.0
10 57 Female GBS (AMAN) 20 149.25 31 159.55
11 45 Male Myasthenic crisis 36 53 40 179